The spouse of a patient newly diagnosed with mild, unilateral symptoms of Parkinson disease (PD) asks the nurse what, besides medication, can be done to manage the disease. The nurse will:

A) CSF proteins and an angiography: While cerebrospinal fluid (CSF) analysis is a valuable diagnostic tool in multiple sclerosis (MS), angiography is not typically used in diagnosing MS. Angiography is primarily used to assess blood vessels and would not help in diagnosing a neurological condition like MS, which involves the central nervous system's myelin sheath.
B) Serum anti-acetylcholine antibodies and x-rays: Anti-acetylcholine antibodies are more relevant for diagnosing autoimmune conditions such as myasthenia gravis, not multiple sclerosis. Additionally, x-rays are not useful for diagnosing MS, as MS is primarily a disorder of the central nervous system, and x-rays are not effective in visualizing soft tissues or brain lesions associated with MS.
C) Serum albumin and a computed tomography (CT) scan: Serum albumin levels are not relevant for diagnosing MS. A CT scan may be used in some cases to rule out other conditions, but magnetic resonance imaging (MRI) is more sensitive and specific for diagnosing MS. MRI is particularly effective in detecting the plaques or lesions in the brain and spinal cord that are characteristic of MS.
D) Cerebrospinal fluid (CSF) and magnetic resonance imaging (MRI): This is the correct combination of diagnostic tests for multiple sclerosis. CSF analysis can show elevated levels of immunoglobulin G (IgG) and oligoclonal bands, which are common in MS. MRI is the most sensitive imaging tool for detecting the characteristic plaques or demyelinated areas in the brain and spinal cord, which are hallmarks of MS. Therefore, this combination is the gold standard for confirming the diagnosis of MS.

A) Parkinson disease is characterized by an imbalance of dopamine and acetylcholine:
The decrease in dopamine results in an imbalance between dopamine and acetylcholine. Normally, dopamine and acetylcholine work in a balanced manner to regulate motor control. As dopamine levels decrease in Parkinson's disease, acetylcholine's effects become more prominent, leading to motor symptoms such as tremors, rigidity, and bradykinesia (slowness of movement).

B) Parkinson disease involves increased dopamine production and decreased acetylcholine:
This statement is incorrect. In Parkinson's disease, there is actually a decrease in dopamine production, not an increase. The disease is characterized by the degeneration of dopamine-producing neurons, leading to the motor symptoms typical of Parkinsonism. The imbalance in Parkinson's disease is primarily one of decreased dopamine and relatively increased acetylcholine activity.

C) Alzheimer disease is caused by decreased amounts of dopamine and degeneration of cholinergic neurons:
While Alzheimer's disease does involve a degeneration of cholinergic neurons (specifically those that release acetylcholine), the primary pathology is related to the accumulation of amyloid plaques and tau tangles, not primarily a decrease in dopamine. Alzheimer's disease is primarily associated with a deficiency in acetylcholine, not dopamine, leading to cognitive impairments, rather than motor deficits.

D) Alzheimer disease involves a possible excess of acetylcholine and neuritic plaques:
This statement is incorrect. Alzheimer's disease is characterized by a deficiency of acetylcholine, which plays a crucial role in memory and cognitive function. The hallmark pathologic features of Alzheimer's disease include the presence of neuritic plaques (formed from amyloid beta) and neurofibrillary tangles (composed of tau protein), not an excess of acetylcholine.